Study Activation Survey Results and What it Means for Sites
In this episode, Jake Meyer and Candi Barlow review results from Advarra’s recent survey and discuss study activation success strategies for sites.
Site Technology Guide for Facilitating GCP in Decentralized Trials
Explore GCP considerations for decentralized trials and discover how secure site technology can streamline oversight and management.
IBC Overview eLearning Module
Learn the essentials of institutional biosafety committees (IBCs), their role in research, and how they differ from IRBs in this eLearning module.
Developing a Data Strategy for Clinical Trials
This white paper outlines a data strategy specific to an organization’s unique needs and allows for adjustments as the organization grows and evolves.
Improving Access to Research for Diverse and Underserved Populations
Discover expert insights on enhancing research inclusivity through improved access, stakeholder relationships, and measurable strategies.
The State of Clinical Trial Activation at Sites
Study activation is a necessary part of a clinical trial but can be rather difficult to coordinate efficiently. There is
World’s Largest CRO Leverages Partnership With Integrated Central IBC to Initiate Sites in COVID-19 Vaccine Research at Warp Speed
Discover how IQVIA and Advarra accelerated COVID-19 vaccine trials with IBC approvals in under two days, activating sites 71% faster.
What Is an Institutional Biosafety Committee?
An Institutional Biosafety Committee (IBC) evaluates risks in gene therapy research to ensure safety and compliance with NIH guidelines. Learn when IBC review is needed.
What is Coverage Analysis in Clinical Research?
Effective coverage analysis is crucial for billing compliance, helping sites avoid financial penalties and protect their study’s integrity.
The State of Clinical Trial Activation at Sites Report
Explore Advarra’s Study Activation Report to uncover roadblocks, survey findings, and solutions to streamline clinical trial activation at sites.
Meridian Builds Robust Gene Therapy Research Program
Discover how Meridian partnered with Advarra to ensure safety and streamline gene therapy research, including swift IBC approvals in just four days.
Retention in Clinical Trials: Keeping Patients on Protocols
While patient recruitment is key to starting a clinical trial, patient retention may be more critical in ensuring the trial